$REPL 4 SEC Filings

Filed On	Filing
24 Aug 2026	Form 4: Astley-Sparke Philip, Director Gave 50,000 shares as a gift
19 Aug 2026	Form 4: Hill Emily Luisa, Chief Financial Officer Sold 9,256 shares ($132K)
12 Aug 2026	Form 4: Patel Sushil, Director Sold 39,341 shares ($510K)
12 Aug 2026	Form 4: Hill Emily Luisa, Chief Financial Officer Sold 11,448 shares ($148K)
12 Aug 2026	Form 4: Xynos Konstantinos, Chief Medical Officer Sold 11,447 shares ($148K)
12 Aug 2026	Form 4: Schwendenman Andrew, Chief Accounting Officer Sold 7,632 shares ($99K)
11 Aug 2026	Form 4: Baker Bros. Advisors Lp, Director and 5 others Acquired 2,736,340 2026 $0.0001 Prefunded Warrants (Open Market Purchase) ($33M)
03 Jun 2026	Form 4: Sarchi Christopher, Chief Commercial Officer Sold 12,000 shares ($111K)
20 May 2026	Form 4: Xynos Konstantinos, Chief Medical Officer Sold 14,023 shares ($71.2K)
20 May 2026	Form 4: Schwendenman Andrew, Chief Accounting Officer Sold 7,894 shares ($40.1K)
20 May 2026	Form 4: Sarchi Christopher, Chief Commercial Officer Sold 8,626 shares ($43.8K)
20 May 2026	Form 4: Astley-Sparke Philip, Director Sold 17,657 shares ($89.7K)
20 May 2026	Form 4: Patel Sushil, Director Sold 37,324 shares ($190K)
20 May 2026	Form 4: Hill Emily Luisa, Chief Financial Officer Sold 7,812 shares ($39.7K)
07 Apr 2026	Form 4: Baker Bros. Advisors Lp, Director and 5 others Granted 89,000 Non-Qualified Stock Option (right to buy)uy)
07 Apr 2026	Form 4: Sarchi Christopher, Chief Commercial Officer Received 50,000 shares as a grant or award · Granted 75,000 Employee Stock Option (right to buy)
07 Apr 2026	Form 4: Astley-Sparke Philip, Director Received 50,000 shares as a grant or award · Granted 75,000 Stock Option (right to buy)
07 Apr 2026	Form 4: Oliger Christy J., Director Granted 44,500 Stock Option (right to buy)
07 Apr 2026	Form 4: Xynos Konstantinos, Chief Medical Officer Received 50,000 shares as a grant or award · Granted 75,000 Employee Stock Option (right to buy)
07 Apr 2026	Form 4: Balachandran Madhavan, Director Granted 44,500 Stock Option (right to buy)

Comments